$JKSM
Jacksam Corp

2023 Q4 Form 10-Q Financial Statement

#000147793223009287 Filed on December 21, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $234.1K $190.7K $492.9K
YoY Change -40.16% -61.3% -74.72%
Cost Of Revenue $471.3K $92.61K $431.5K
YoY Change 1.21% -78.54% -68.14%
Gross Profit -$237.2K $98.14K $61.44K
YoY Change 218.43% 59.74% -89.68%
Gross Profit Margin -101.34% 51.45% 12.46%
Selling, General & Admin $59.96K $88.78K $174.8K
YoY Change -90.28% -49.22% -32.14%
% of Gross Profit 90.47% 284.57%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $100.00 $290.00 $140.00
YoY Change 0.0% 107.14% -72.0%
% of Gross Profit 0.3% 0.23%
Operating Expenses $59.97K $111.8K $397.6K
YoY Change -90.28% -71.87% -31.65%
Operating Profit -$297.2K -$13.70K -$336.1K
YoY Change -57.01% -95.92% -2560.66%
Interest Expense -$422.7K $39.91K $53.03K
YoY Change -16.49% -24.74% -76.1%
% of Operating Profit
Other Income/Expense, Net $0.00 $1.064M $17.70K
YoY Change 5912.31% -114.05%
Pretax Income -$719.9K $1.051M -$318.4K
YoY Change -39.88% -429.96% 183.49%
Income Tax
% Of Pretax Income
Net Earnings -$743.3K $1.051M -$318.4K
YoY Change -39.12% -429.96% 183.49%
Net Earnings / Revenue -317.5% 550.81% -64.6%
Basic Earnings Per Share $0.01 $0.00
Diluted Earnings Per Share -$0.01 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 81.09M shares 81.09M shares 81.09M shares
Diluted Shares Outstanding 214.9M shares 80.86M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $145.5K $145.5K $298.8K
YoY Change -69.87% -51.29% -51.19%
Cash & Equivalents $145.5K $145.5K $298.8K
Short-Term Investments
Other Short-Term Assets $77.63K $83.81K $94.38K
YoY Change 85.94% -11.2% 581.44%
Inventory $0.00 $216.0K $208.5K
Prepaid Expenses $77.63K $83.81K $94.38K
Receivables $9.520K $25.61K $874.3K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $232.7K $470.9K $1.476M
YoY Change -68.51% -68.09% -0.84%
LONG-TERM ASSETS
Property, Plant & Equipment $44.09K $229.00 $613.00
YoY Change 8428.05% -62.64% -66.61%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $44.09K $52.94K $86.21K
YoY Change -43.61% -38.59% 4595.53%
TOTAL ASSETS
Total Short-Term Assets $232.7K $470.9K $1.476M
Total Long-Term Assets $44.09K $52.94K $86.21K
Total Assets $276.8K $523.9K $1.562M
YoY Change -66.13% -66.46% 4.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $292.9K $275.5K $763.6K
YoY Change 19.32% -63.93% 67.17%
Accrued Expenses $2.145M $2.103M $2.500M
YoY Change 7.81% -15.87% 28.63%
Deferred Revenue
YoY Change
Short-Term Debt $50.00K $50.00K $0.00
YoY Change
Long-Term Debt Due $1.064M $1.070M $556.8K
YoY Change 76.48% 92.13% -14.87%
Total Short-Term Liabilities $5.115M $5.814M $4.559M
YoY Change 1.53% 27.54% -5.18%
LONG-TERM LIABILITIES
Long-Term Debt $138.0K $138.9K $620.0K
YoY Change -76.22% -77.61% -26.94%
Other Long-Term Liabilities $6.980K $17.23K $55.12K
YoY Change -84.9% -68.74%
Total Long-Term Liabilities $145.0K $156.1K $675.2K
YoY Change -76.86% -76.88% -20.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.115M $5.814M $4.559M
Total Long-Term Liabilities $145.0K $156.1K $675.2K
Total Liabilities $5.260M $5.970M $5.234M
YoY Change -7.14% 14.07% -7.47%
SHAREHOLDERS EQUITY
Retained Earnings -$13.91M -$13.19M -$11.45M
YoY Change 9.95% 15.16% 4.69%
Common Stock $81.09K $81.09K $81.09K
YoY Change 0.0% 0.0% 10.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$4.983M -$5.728M -$3.941M
YoY Change
Total Liabilities & Shareholders Equity $276.8K $523.9K $1.562M
YoY Change -66.13% -66.46% 4.82%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income -$743.3K $1.051M -$318.4K
YoY Change -39.12% -429.96% 183.49%
Depreciation, Depletion And Amortization $100.00 $290.00 $140.00
YoY Change 0.0% 107.14% -72.0%
Cash From Operating Activities $5.220K $53.36K -$82.83K
YoY Change -97.17% -164.42% -82.54%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.230K -740.0 7.950K
YoY Change 1088.64% -109.31% -97.58%
NET CHANGE
Cash From Operating Activities 5.220K 53.36K -82.83K
Cash From Investing Activities
Cash From Financing Activities -5.230K -740.0 7.950K
Net Change In Cash -10.00 52.62K -74.88K
YoY Change -100.01% -170.27% -48.78%
FREE CASH FLOW
Cash From Operating Activities $5.220K $53.36K -$82.83K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
444444 usd
dei Entity Central Index Key
EntityCentralIndexKey
0000860543
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000 shares
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
81088719 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
81088719 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
81088719 shares
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
158672 usd
CY2022 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
264659 usd
CY2022 jksm Inventory Allowance
InventoryAllowance
18800 usd
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
15189056 shares
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
14279965 shares
us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
2469136 shares
us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
18066667 shares
CY2022Q4 jksm Increased The Authorized Common Shares
IncreasedTheAuthorizedCommonShares
230000000 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
033-33263
dei Entity Registrant Name
EntityRegistrantName
JACKSAM CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-3566284
dei Entity Address Address Line1
EntityAddressAddressLine1
3100 Airway Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 138
dei Entity Address City Or Town
EntityAddressCityOrTown
Costa Mesa
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92626
dei City Area Code
CityAreaCode
800
dei Local Phone Number
LocalPhoneNumber
605-3580
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
JKSM
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
81088719 shares
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
482908 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
214143 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
41751 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
738802 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
517 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
77677 usd
CY2022Q4 us-gaap Assets
Assets
816996 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
558879 usd
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
80000 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1127634 usd
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
34007 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
491913 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1642269 usd
CY2022Q4 jksm Subscription Payable Current
SubscriptionPayableCurrent
499999 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5037817 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
580105 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
46233 usd
CY2022Q4 us-gaap Liabilities
Liabilities
5664155 usd
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
272022 usd
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
30000000 shares
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
81088719 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
81088 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7451916 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12652285 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-5119181 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
816996 usd
CY2023Q3 us-gaap Revenues
Revenues
190747 usd
CY2022Q3 us-gaap Revenues
Revenues
492891 usd
us-gaap Revenues
Revenues
1221782 usd
us-gaap Revenues
Revenues
3737275 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
92610 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
431454 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
745511 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2832271 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
98137 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
61437 usd
us-gaap Gross Profit
GrossProfit
476271 usd
us-gaap Gross Profit
GrossProfit
905004 usd
CY2023Q3 us-gaap Salaries And Wages
SalariesAndWages
23059 usd
CY2022Q3 us-gaap Salaries And Wages
SalariesAndWages
222731 usd
us-gaap Salaries And Wages
SalariesAndWages
187220 usd
us-gaap Salaries And Wages
SalariesAndWages
764211 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
88780 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
174832 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
310592 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
550312 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
111839 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
397563 usd
us-gaap Operating Expenses
OperatingExpenses
497812 usd
us-gaap Operating Expenses
OperatingExpenses
1314523 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-13702 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-336126 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-21541 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-409519 usd
CY2023Q3 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
1078040 usd
CY2022Q3 us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
70733 usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
-330806 usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
435730 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
39908 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
53030 usd
us-gaap Interest Expense
InterestExpense
213140 usd
us-gaap Interest Expense
InterestExpense
350153 usd
CY2023Q3 us-gaap Other Income
OtherIncome
26227 usd
CY2022Q3 us-gaap Other Income
OtherIncome
0 usd
us-gaap Other Income
OtherIncome
26227 usd
us-gaap Other Income
OtherIncome
0 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1064359 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
17703 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-517719 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
85577 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1050657 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-318423 usd
us-gaap Net Income Loss
NetIncomeLoss
-539260 usd
us-gaap Net Income Loss
NetIncomeLoss
-323942 usd
CY2023Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
23340 usd
CY2022Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
23340 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
69259 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
69260 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1027317 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-341763 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-608519 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-393202 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81088719 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
80855219 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81088719 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
78700014 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
214896127 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
80855219 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81088719 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
78700014 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-4514303 usd
CY2022Q1 jksm Issuance Of Series B Preferred Stock Net Of Fees Amount
IssuanceOfSeriesBPreferredStockNetOfFeesAmount
890000 usd
CY2022Q1 jksm Common Stock And Warrants Issued In Connection With Preferred Stock Amount
CommonStockAndWarrantsIssuedInConnectionWithPreferredStockAmount
0 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-3617752 usd
CY2022Q2 jksm Common Stock Issued For Share Payable Amount
CommonStockIssuedForSharePayableAmount
0 usd
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
68977 usd
CY2022Q2 jksm Common Stock And Warrants Issued In Connection With Preferred Stock Amount
CommonStockAndWarrantsIssuedInConnectionWithPreferredStockAmount
0 usd
CY2022Q2 jksm Dividends On Series A And B Preferred Stock
DividendsOnSeriesAAndBPreferredStock
-23087 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-34903 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-3606765 usd
CY2022Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
8000 usd
CY2022Q3 jksm Dividends On Series A Preferred Stock
DividendsOnSeriesAPreferredStock
-23340 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-318423 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-3940528 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-5119181 usd
CY2023Q1 jksm Dividends On Series A And B Preferred Stock
DividendsOnSeriesAAndBPreferredStock
-22833 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
55429 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-5086585 usd
CY2023Q2 jksm Dividends On Series A And B Preferred Stock
DividendsOnSeriesAAndBPreferredStock
-23086 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1645346 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-6755017 usd
CY2023Q3 jksm Dividends On Series A And B Preferred Stock
DividendsOnSeriesAAndBPreferredStock
-23340 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1050657 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-5727700 usd
us-gaap Net Income Loss
NetIncomeLoss
-539260 usd
us-gaap Net Income Loss
NetIncomeLoss
-323942 usd
us-gaap Depreciation
Depreciation
288 usd
us-gaap Depreciation
Depreciation
859 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
76977 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
96095 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
63625 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
24962 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
20225 usd
us-gaap Interest Expense Other
InterestExpenseOther
0 usd
us-gaap Interest Expense Other
InterestExpenseOther
141020 usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
-330806 usd
us-gaap Gain Loss On Sale Of Derivatives
GainLossOnSaleOfDerivatives
435730 usd
jksm Impairment Of Inventory
ImpairmentOfInventory
0 usd
jksm Impairment Of Inventory
ImpairmentOfInventory
18800 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-25605 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-283138 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1843 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-30545 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-42054 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-85779 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-25119 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-17916 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
139343 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
324327 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-274250 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-23999 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-316637 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-555216 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
50000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
0 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
300000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
231194 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
69737 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
312009 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
890000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-20737 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
509185 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-337374 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-46031 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
482908 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
344811 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
145534 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
298780 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
8691 usd
us-gaap Interest Paid Net
InterestPaidNet
13709 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
105822 usd
jksm Common Stock Issued For Deferred Finance Costs
CommonStockIssuedForDeferredFinanceCosts
0 usd
jksm Common Stock Issued For Deferred Finance Costs
CommonStockIssuedForDeferredFinanceCosts
2670 usd
jksm Common Stock Issued To Settle Share Payable
CommonStockIssuedToSettleSharePayable
0 usd
jksm Common Stock Issued To Settle Share Payable
CommonStockIssuedToSettleSharePayable
331600 usd
jksm Preferred Stock Dividends Non Cash
PreferredStockDividendsNonCash
69259 usd
jksm Preferred Stock Dividends Non Cash
PreferredStockDividendsNonCash
45920 usd
CY2022Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-70733 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
339540 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-435730 usd
CY2023Q3 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
0 usd
CY2022Q3 us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
0 usd
us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
0 usd
us-gaap Interest On Convertible Debt Net Of Tax
InterestOnConvertibleDebtNetOfTax
0 usd
CY2023Q3 jksm Net Income Loss For Dilutive Calculation
NetIncomeLossForDilutiveCalculation
-14030 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements is in conformity with U.S. GAAP and requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Such estimates and assumptions impact both assets and liabilities, including but not limited to net realizable value of accounts receivable and inventory, estimated useful lives and potential impairment of property and equipment, estimate of fair value of share-based payments and derivative liabilities, estimates of fair value of warrants issued and recorded as debt discount and estimates of the probability and potential magnitude of contingent liabilities. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future nonconforming events. Accordingly, actual results could differ significantly from estimates.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company’s operations are subject to risk and uncertainties including financial, operational, regulatory and other risks including the potential risk of business failure. The Company has experienced, and in the future, expects to continue to experience, variability in its sales and earnings. The factors expected to contribute to this variability include, among others, (i) the uncertainty associated with the commercialization and ultimate success of the product, (ii) competition inherent at large national retail chains where product is expected to be sold, (iii) general economic conditions, and (iv) the related volatility of prices pertaining to the cost of sales. During the three months ended September 30, 2023 four customers accounted for 44%, 16%, 11% and 10% of revenue. During the three months ended September 30, 2022, two customers accounted for 14% and 11% of revenue. During the nine months ended September 30, 2023, three customers accounted for 27%, 16% and 14% of revenue. During the nine months ended September 30, 2022, three customers accounted for 11%, 10% and 10% of revenue.</p>
CY2023Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
264659 usd
jksm Inventory Allowance
InventoryAllowance
18800 usd
CY2022Q3 jksm Net Income Loss For Dilutive Calculation
NetIncomeLossForDilutiveCalculation
-389156 usd
jksm Net Income Loss For Dilutive Calculation
NetIncomeLossForDilutiveCalculation
-199720 usd
jksm Net Income Loss For Dilutive Calculation
NetIncomeLossForDilutiveCalculation
-759672 usd
jksm Weighted Average Shares Outstanding
WeightedAverageSharesOutstanding
81088719 shares
CY2022Q3 jksm Weighted Average Shares Outstanding
WeightedAverageSharesOutstanding
80132342 shares
CY2023Q3 jksm Weighted Average Shares Outstanding
WeightedAverageSharesOutstanding
81088719 shares
jksm Weighted Average Shares Outstanding
WeightedAverageSharesOutstanding
77605012 shares
jksm Future Revenue Recognized
FutureRevenueRecognized
853384 usd
CY2023Q3 us-gaap Revenues
Revenues
190747 usd
CY2022Q3 us-gaap Revenues
Revenues
492891 usd
us-gaap Revenues
Revenues
1221782 usd
us-gaap Revenues
Revenues
3737275 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
1027317 usd
CY2022Q3 us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-341763 usd
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-608519 usd
us-gaap Net Income Loss Attributable To Parent Diluted
NetIncomeLossAttributableToParentDiluted
-393202 usd
CY2023Q3 jksm Dividends Preferred Stock1
DividendsPreferredStock1
23340 usd
CY2022Q3 jksm Dividends Preferred Stock1
DividendsPreferredStock1
23340 usd
jksm Dividends Preferred Stock1
DividendsPreferredStock1
69259 usd
jksm Dividends Preferred Stock1
DividendsPreferredStock1
69260 usd
CY2023Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1064687 usd
CY2023Q3 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
18066667 usd
CY2022Q3 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
0 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
0 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
0 usd
CY2023Q3 jksm Dilutive Effect Of Convertible Debt
DilutiveEffectOfConvertibleDebt
115740741 shares
CY2023Q3 jksm Weighted Average Shares Outstanding For Diluted Net Income Loss Per Share
WeightedAverageSharesOutstandingForDilutedNetIncomeLossPerShare
214896127 usd
CY2022Q3 jksm Weighted Average Shares Outstanding For Diluted Net Income Loss Per Share
WeightedAverageSharesOutstandingForDilutedNetIncomeLossPerShare
80132342 usd
jksm Weighted Average Shares Outstanding For Diluted Net Income Loss Per Share
WeightedAverageSharesOutstandingForDilutedNetIncomeLossPerShare
81088719 usd
jksm Weighted Average Shares Outstanding For Diluted Net Income Loss Per Share
WeightedAverageSharesOutstandingForDilutedNetIncomeLossPerShare
77605012 usd
CY2023Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
15189056 shares
CY2023Q3 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
115740741 shares
CY2023Q3 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
18066667 shares
CY2022Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
14279965 shares
CY2022Q3 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
2469136 shares
CY2022Q3 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
18066667 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
2777778 shares
CY2022Q3 jksm Share Payable Equity Issued
SharePayableEquityIssued
2222223 shares
CY2023Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
0 usd
CY2022Q3 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
1000 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
220 usd
us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
26500 usd
CY2023Q3 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
698221 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
558879 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
20644 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
20644 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20415 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20127 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
229 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
517 usd
us-gaap Depreciation
Depreciation
288 usd
us-gaap Depreciation
Depreciation
859 usd
CY2023Q3 us-gaap Notes Payable
NotesPayable
764135 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
832872 usd
CY2023Q3 jksm Debt Instrument Unamortized Discount1
DebtInstrumentUnamortizedDiscount1
0 usd
CY2022Q4 jksm Debt Instrument Unamortized Discount1
DebtInstrumentUnamortizedDiscount1
-94095 usd
CY2023Q3 us-gaap Notes Payable Current
NotesPayableCurrent
625283 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
158672 usd
CY2023Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
138852 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
580105 usd
CY2023Q3 jksm Principal Amount
PrincipalAmount
50000 usd
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.10 pure
us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2023-06-30
us-gaap Deferred Purchased Power Costs
DeferredPurchasedPowerCosts
1000 usd
jksm Amortization Of Debt Discount
AmortizationOfDebtDiscount
96095 usd
jksm Amortization Of Debt Discount
AmortizationOfDebtDiscount
63625 usd
CY2023Q3 us-gaap Accounts Payable Interest Bearing Noncurrent
AccountsPayableInterestBearingNoncurrent
278199 usd
CY2022Q4 us-gaap Accounts Payable Interest Bearing Noncurrent
AccountsPayableInterestBearingNoncurrent
168844 usd
CY2023Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
444444 usd
CY2022Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
444444 usd
CY2023Q3 jksm Debt Discount And Deferred Finance Costs On Short Term Convertible Notes
DebtDiscountAndDeferredFinanceCostsOnShortTermConvertibleNotes
0 usd
CY2022Q4 jksm Debt Discount And Deferred Finance Costs On Short Term Convertible Notes
DebtDiscountAndDeferredFinanceCostsOnShortTermConvertibleNotes
0 usd
CY2023Q3 jksm Current Convertible Notes Payable Net Of Discount
CurrentConvertibleNotesPayableNetOfDiscount
444444 usd
CY2022Q4 jksm Current Convertible Notes Payable Net Of Discount
CurrentConvertibleNotesPayableNetOfDiscount
444444 usd
CY2023Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
CY2022Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
444444 usd
jksm Gain Loss On Changes In Fair Value Derivatives
GainLossOnChangesInFairValueDerivatives
-330806 usd
jksm Gain Loss On Changes In Fair Value Derivatives
GainLossOnChangesInFairValueDerivatives
-435730 usd
CY2023Q3 jksm Increased The Authorized Common Shares
IncreasedTheAuthorizedCommonShares
230000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 jksm Common Stock Designated
CommonStockDesignated
200000000 shares
CY2023Q3 jksm Preferred Stock Designated
PreferredStockDesignated
30000000 shares
CY2023Q3 jksm Shares Balance Of Subscriptions Payable Liability
SharesBalanceOfSubscriptionsPayableLiability
2777778 shares
CY2022Q4 jksm Subscriptions Payable Liability Balance
SubscriptionsPayableLiabilityBalance
499999 usd
us-gaap Dividends
Dividends
9424 usd
CY2023Q3 jksm Accrued Dividend
AccruedDividend
29446 usd
CY2022Q4 jksm Accrued Dividend
AccruedDividend
20022 usd
jksm Redemption Value
RedemptionValue
281446 usd
CY2022 jksm Redemption Value
RedemptionValue
272022 usd
jksm Shares Remaining To Be Issued
SharesRemainingToBeIssued
2000000 shares
jksm Fair Value Of Common Stock
FairValueOfCommonStock
139800 usd
jksm Aggregate Number Of Stock Warrant Beginning Balance
AggregateNumberOfStockWarrantBeginningBalance
14279965 shares
jksm Aggregate Stock Warrant Exercise Price Beginning Balance
AggregateStockWarrantExercisePriceBeginningBalance
2946044 usd
jksm Weighted Average Stock Warrant Exercise Price Beginning Balance
WeightedAverageStockWarrantExercisePriceBeginningBalance
0.21
jksm Aggregate Exercise Price Granted
AggregateExercisePriceGranted
0 usd
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
jksm Aggregate Exercise Price Exercised
AggregateExercisePriceExercised
0 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
2211389 shares
jksm Aggregate Exercise Price Forfeited And Cancelled
AggregateExercisePriceForfeitedAndCancelled
-631200 usd
jksm Aggregate Number Of Stock Warrant Ending Balance
AggregateNumberOfStockWarrantEndingBalance
12068576 shares
jksm Aggregate Stock Warrant Exercise Price Ending Balance
AggregateStockWarrantExercisePriceEndingBalance
2314844 usd
jksm Weighted Average Stock Warrant Exercise Price Ending Balance
WeightedAverageStockWarrantExercisePriceEndingBalance
0.19
us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P1Y6M25D
jksm Lease Agreement Period
LeaseAgreementPeriod
beginning February 15, 2022 through February 28, 2025
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
3267 usd
jksm Lease Payments Increased Percentage
LeasePaymentsIncreasedPercentage
0.04 pure
CY2023Q3 jksm Right Of Use Asset And Lease Liability
RightOfUseAssetAndLeaseLiability
105822 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
30163 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
26811 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
5837 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
24220 usd
us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
us-gaap Variable Lease Cost
VariableLeaseCost
0 usd
us-gaap Sublease Income
SubleaseIncome
0 usd
us-gaap Sublease Income
SubleaseIncome
0 usd
us-gaap Lease Cost
LeaseCost
36000 usd
us-gaap Lease Cost
LeaseCost
51031 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
52715 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
77677 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
37891 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
34007 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
17230 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
46233 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
55121 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
80240 usd
CY2023Q3 jksm Incremental Borrowing Rate Percentage
IncrementalBorrowingRatePercentage
0.10 pure
jksm Lease Remaining Terms
LeaseRemainingTerms
P1Y8M1D
us-gaap Long Term Debt Weighted Average Interest Rate Over Time
LongTermDebtWeightedAverageInterestRateOverTime
0.10 pure
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
10193 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
42123 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
7065 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
0 usd
CY2023Q3 jksm Lessee Operating Lease Liability Payments Due After Year Three
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearThree
0 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
59381 usd
CY2023Q3 jksm Interest Lessee Operating Lease Liability
InterestLesseeOperatingLeaseLiability
-4260 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
55121 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1642269 usd

Files In Submission

Name View Source Status
jksm-20230930_lab.xml Edgar Link unprocessable
jksm-20230930_pre.xml Edgar Link unprocessable
0001477932-23-009287-index-headers.html Edgar Link pending
0001477932-23-009287-index.html Edgar Link pending
0001477932-23-009287.txt Edgar Link pending
0001477932-23-009287-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
jksm-20230930.xsd Edgar Link pending
jksm-20230930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
jksm-20230930_def.xml Edgar Link unprocessable
jksm_10q.htm Edgar Link pending
jksm_ex311.htm Edgar Link pending
jksm_ex321.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
jksm_10q_htm.xml Edgar Link completed